Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week oral niacin trial in coronary artery disease with dyslipidemia
ISRCTN48365122Phase 4Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and dyslipidemia comparing Niacin plus standard long-term CAD therapy with Placebo plus standard long-term CAD therapy (2 arms). Started Jan 2006; status: completed.
02
Drugs
niacin
03
Conditions
coronary arteriosclerosisdyslipidemia
Beyond the preview
Go deeper on ISRCTN48365122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48365122.